Delivery Order SPE2DB22D2214-SPE2DB24FS5QB
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,820,315 units of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The $1,284.83 contract has a firm fixed price and was awarded on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,426,593 units of Ondansetron ODT 4 mg tablets in 30-count packages. The $7,658.27 firm fixed price award was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 13, 2024. The contract is not a set-aside and is a delivery order issued under DLA's broader medical supplies and pharmaceutical Indefinite Delivery Contract (IDC), which has a potential value...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,564,943,555 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The $24,544.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The $1,068.42 fixed-price delivery order is for the supply of 4,564,731,173 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count bottles. The contract has a completion date of May 29, 2024 and was awarded on May 28, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,801,874 units of Ondansetron ODT 4 mg tablets. The $14,147.81 contract was awarded on June 4, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of June 5, 2024. The contract is structured as a firm fixed-price Delivery Order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $10,495.91 to provide 4,564,185,602 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This contract, which has an ultimate completion date of April 8, 2024, was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued up to $999,999,999.00 with a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,298,868 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The $3,125.70 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 16, 2024 with a completion date of April 17, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,816,939 units of Ondansetron ODT 4 MG Tablet 30S, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,717.81, is a Delivery Order under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...